Beilstein J. Org. Chem. 2010, 6, 1159–1166.
Hz and 1.3 Hz, 1H, CH), 6.75 (d, J = 8.9 Hz, 1H, CH), 6.91 CDCl3, δ): 1.13 (d, J = 6.1 Hz, 6H, 2 CH3), 2.34 (s, 18H, 6
(dd, J = 17.8 Hz and 11.2 Hz, 1H, CH), 6.99 (dd, J = 8.9 Hz CH), 4.08 (s, 4H, 2 CH2), 4.72 (sept, J = 6.1 Hz, 1H, CH), 6.54
and 2.7 Hz, 1H, CH), 7.24 (d, J = 2.7 Hz, 1H, CH), 8.00 (d, J = (d, J = 8.7 Hz, 1H, CH), 6.61 (d, J = 2.2 Hz, 1H, CH), 6.98 (s,
8.6 Hz, 1H, CH), 8.37 (dd, J = 8.6 Hz and 2.2 Hz, 1H, CH), 4H, CH), 7.08 (dd, J = 8.7 and 2.2 Hz, 1H, CH), 16.21 (s, 1H,
8.65 (d, J = 2.2 Hz, 1H, CH). 13C NMR (100 MHz, CDCl3, δ): CH). 19F (376 MHz, CDCl3, δ): -75.72 (s, 3F)
22.0 (2C), 71.2, 114.2, 115.6, 116.4, 119.0, 122.5, 127.7, 129.2,
129.9, 131.3, 134.7, 140.5, 144.0, 146.3, 152.1.
(1,3-dimesitylimidazolidin-2-ylidene)(2-isopropoxy-5-(4-nitro-
phenylsulfonamido)benzylidene)ruthenium(II) chloride (4b):
N-(4-isopropoxy-3-vinylphenyl)-2,3,4,5,6-pentafluorobenzene- Following the general procedure using the ligand 6b, complex
sulfonamide (6e): Following the procedure described for 6b 4b was isolated as a green powder (55 mg, 71%). 1H NMR (400
using 2,3,4,5,6-pentafluorobenzenesulfonyl chloride, 6e was MHz, CDCl3, δ): 1.21 (d, J = 6.1 Hz, 6H, 2 CH3), 2.42 (s, 18H,
obtained as a red oil (65 mg, 71%). 1H NMR (400 MHz, 6 CH), 4.19 (s, 4H, 2CH2), 4.84 (sept, J = 6.1 Hz, 1H, CH),
CDCl3, δ): 1.32 (d, J = 6.1 Hz, 6H, 2 CH3), 4.49 (sept, J = 6.1 6.57 (d, J = 7.3 Hz, 1H, CH), 6.71 (bs, 1H, NH), 6.95 (d, J =
Hz, 1H, CH), 5.27 (dd, J = 11.2 Hz and 1.1 Hz, 1H, CH), 5.67 7.1 Hz, 1H, CH), 7.08 (s, 4H, 4 CH), 7.33 (s, 1H, CH), 7.91 (d,
(dd, J = 17.8 Hz and 1.1 Hz, 1H, CH), 6.79 (d, J = 8.8 Hz, 1H, J = 7.1 Hz, 2H, 2 CH), 8.27 (d, J = 7.3 Hz, 2H, 2 CH), 16.34 (s,
CH), 6.93 (dd, J = 17.8 Hz and 11.2 Hz, 1H, CH), 7.04 (dd, J = 1H, CH).
8.8 Hz and 2.7 Hz, 1H, CH), 7.19 (s, 1H, NH), 7.25 (d, J = 2.7
Hz, 1H, CH). 13C NMR (100 MHz, CDCl3, δ): 22.0 (2C), 71.2, (1,3-dimesitylimidazolidin-2-ylidene)(2-isopropoxy-5-(2-nitro-
114.7, 115.5, 121.1, 123.1, 126.9, 127.5–131.2 (dm, J = 245 phenylsulfonamido)benzylidene)ruthenium(II) chloride (4c):
Hz), 129.0, 130.8,135.3-138.3 (dm, J = 256 Hz), 142.2–145.1 Following the general procedure using the ligand 6c, complex
(dm, J = 259 Hz), 154.1. 19F NMR (376 MHz, CDCl3, δ): −158 4c was isolated as a green powder (78 mg, 74%). 1H NMR
(2F), −144.7 (1F), −136 (2F).
(400 MHz, CDCl3, δ): 1.09 (d, J = 6.1 Hz, 6H, 2 CH3), 2.30 (s,
18H, 6 CH3), 4.07 (s, 4H, 2 CH2), 4.71 (sept., J = 6.1 Hz, 1H,
N-(4-isopropoxy-3-vinylphenyl)-3,5-bis(trifluoromethyl)- CH), 6.64 (d, J = 8.8 Hz, 1H, CH), 6.66 (d, J = 2.6 Hz, 1H,
benzenesulfonamide (6f): Following the procedure described CH), 6.95 (s, 4H, 4 CH), 7.15 (s, 1H, CH), 7.33 (dd, J = 8.8 and
for 6b using 3,5-bis(trifluoromethyl)benzenesulfonyl chloride, 2.6 Hz, 1H, CH), 7.51 (dt, J = 7.7 and 1.2 Hz, 1H, CH), 7.64
6f was obtained as a brown solid (81 mg, 79%). 1H NMR (400 (dt, J = 7.8 and 1.4 Hz, 1H, CH), 7.70 (dd, J = 7.8 and 1.3 Hz,
MHz, CDCl3, δ): 1.32 (d, J = 6.1 Hz, 6H), 4.48 ( sept., J = 6.1 1H, CH), 7.79 (dd, J = 8.0 and 1.1 Hz, 1H, CH), 16.14 (s, 1H,
Hz, 1H), 5.22 (dd, J = 1.2 and 11.2 Hz, 1H), 5.57 (dd, J = 1.2 CH).
and 17.8 Hz, 1H), 6.78 (d, J = 8.84 Hz, 1H), 6.92 (m, 2H), 7.02
(s, 1H), 7.12 (d, J = 2.7 Hz, 1H), 8.03 (s, 1H), 8.14 (s, 2H). 13C (1,3-dimesitylimidazolidin-2-ylidene)(5-(2,4-dinitrophenylsul-
NMR (100 MHz, CDCl3, δ): 21.9 (2C), 71.3, 114.8, 115.2, fonamido)-2-isopropoxybenzylidene)ruthenium(II) chloride
122.4 (q, 270 Hz, 2C), 123.0, 124.9, 126.3 (q, J = 3.7 Hz, 2C), (4d): Following the general procedure using the ligand 6d, com-
127.2, 127.6 (2C), 129.1, 130.7, 132.7 (q, 34.0 Hz, 2C), 141.5, plex 4d was isolated as a green powder (55 mg, 65%). 1H NMR
154.3. 19F NMR (376 MHz, CDCl3, δ): −63.1.
(400 MHz, CDCl3, δ): 1.09 (d, J = 6.1 Hz, 6H, 2 CH3), 2.31 (s,
18H, 6 CH3), 4.07 (s, 4H, 2 CH2), 4.70 (sept., J = 6.1 Hz, 1H,
General procedure for catalyst formation: To a solution of cata- CH), 6.64 (d, J = 8.7 Hz, 1H, CH), 6.73 (d, J = 2.4 Hz, 1H,
lyst 7 and copper chloride (1.1 equiv) in dry DCM (1 mL for CH), 6.96 (s, 4H, 4 CH), 7.33 (dd, J = 8.6 and 2.4 Hz, 1H, CH),
0.02 mmol of Ru-indenylidene complex) was added a solution 7.98 (d, J = 8.6 Hz, 1H, CH), 8.28 (dd, J = 8.6 and 2.2 Hz, 1H,
of 6a–f (1 equiv) in DCM (1 mL for 0.05 mmol of ligand). The CH), 8.56 (d, J = 2.2 Hz, 1H, CH), 16.17 (s, 1H, CH).
resulting mixture was stirred at 35 °C for 5 h. Volatiles were
removed under reduced pressure, acetone was added to the (1,3-dimesitylimidazolidin-2-ylidene)(2-isopropoxy-5-(perfluo-
residue, and the solution was filtered trough a pad of Celite. The rophenylsulfonamido)benzylidene)ruthenium(II) chloride (4e):
filtrate was concentrated and purified by chromatography on Following the general procedure using the ligand 6e, complex
silica gel (pentane/acetone, 75/25) to yield the expected 4e was isolated as a green powder (69 mg, 78%). 1H NMR (400
complexes 4a–i.
MHz, CDCl3, δ): 1.09 (d, J = 6.1 Hz, 6H, 2 CH3), 2.33 (s, 18H,
6 CH3), 4.08 (s, 4H, 2 CH2), 4.72 (sept., J = 6.1 Hz, 1H, CH),
(1,3-dimesitylimidazolidin-2-ylidene)(2-isopropoxy-5-(trifluo- 6.61 (d, J = 8.8 Hz, 1H, CH), 6.67 (d, J = 2.5 Hz, 1H, CH),
romethylsulfonamido)benzylidene)ruthenium(II) chloride (4a): 6.98 (s, 4H, 4 CH), 7.24 (dd, J = 8.8 and 2.5 Hz, 1H, CH),
Following the general procedure using the ligand 6a, complex 16.20 (s, 1H, CH). 19F NMR (376 MHz, CDCl3, δ): −159.1
4a was isolated as a green powder (62 mg, 73%). 1H (400 MHz, (2F), −145.6 (1F), −137.2 (2F).
1164